Navigation Links
Hospira Reports Second-Quarter 2008 Results
Date:8/6/2008

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.
Private Securities Litigation Reform Act of 1995 --

A Caution Concerning Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including projections of certain measures of Hospira's results of operations, projections of certain charges and expenses, statements regarding the financial impact of the acquisition of Mayne Pharma, and other statements regarding Hospira's goals, strategy, expectations and commitments. Hospira cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Hospira's operations and may cause actual results to be materially different from expectations include the risks, uncertainties and factors discussed under the headings "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Hospira's latest Annual Report on Form 10-K, and Hospira's subsequent Quarterly Reports on Form 10-Q, which are filed with the Securities and Exchange Commission, and incorporated by reference. Hospira undertakes no obligation to release
'/>"/>

SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related medicine news :

1. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
2. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
3. Hospira Reports Third-Quarter 2007 Results
4. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
5. Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
6. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
7. Hospira Launches Generic Irinotecan Injection
8. Hospira Reports Fourth-Quarter and Full-Year 2007 Results
9. Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13
10. Hospira Hosts Conference Call for First-Quarter 2008 Earnings
11. Hospira Acquires Sculptor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 2015 On November 24, 2014, Per Wickstrom ... to discuss the problem of substance abuse and the solutions ... of drug abuse and recovery, gives a unique first-person perspective ... his teammates on the New York Giants, Taylor’s early career ... drug tests, yet he was able to straighten out long ...
(Date:3/31/2015)... Angeles, CA (PRWEB) March 31, 2015 ... references on the Internet, is proudly enduring adding news ... cosmetic doctors and the consumers of plastic surgery and ... With more user-friendly pages and interconnected sections, the Cosmetic ... The newest addition to the Cosmetic Town site navigation, ...
(Date:3/31/2015)... The American College of Traditional Chinese ... April will include interesting workshops, lectures and more. The ... a.m. April 6, ACTCM welcomes the newest cohort. The ... Pioneer Square Campus located at 555 DeHaro St. , ... 14, Students will be updated on the upcoming merger ...
(Date:3/31/2015)... Stamford, CT (PRWEB) March 31, 2015 Calling ... fight against Lyme and other tick-borne diseases! The first annual ... at Cove Island Park in Stamford, CT. The event, hosted ... Alliance (TBDA), will raise funds to support research and ... family event, open to all ages and abilities, will feature ...
(Date:3/31/2015)... Medical DNA Labs, LLC, An Affiliate of Physician ... Accreditation by COLA, a national healthcare accreditation organization. ... standards of quality in day-to-day operations, demonstrate continued accuracy ... rigorous on-site laboratory survey. Medical DNA Labs, LLC ... long-term commitment to provide quality service to its patients. ...
Breaking Medicine News(10 mins):Health News:Lawrence Taylor & Per Wickstrom Discuss the Drug Rehabilitation & Recovery Process 2Health News:Cosmetic Town is Now Transforming so Consumer can Better Navigate 2Health News:ACTCM Announces April Event Schedule 2Health News:Lyme Research Alliance & Tick-Borne Disease Alliance to Kick-Off 1st “Lyme Walk & Run” Event, April 26 2Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2
... June 29 Air Methods Corporation (Nasdaq: AIRM ... announced today it has filed a petition with the National ... cause determination related to the June 29, 2008 mid-air collision ... states that "both pilots failed to see and avoid the ...
... Helicobacter pylori survives in the body by manipulating ... thesis from the Sahlgrenska Academy at the University of ... against the common peptic ulcer bacterium. About half ... mainly in the stomach. Most infected individuals never experience ...
... Black gay men have less choice when it comes to sexual ... are closely knit. These tightly interconnected networks make the rapid spread ... social and sexual mixing between ethnic groups in men who have ... San Francisco Department of Public Health in the US, show that ...
... new study by The Pew Charitable Trusts, Philadelphia Research Initiative reports ... money it needs to make good on its obligation to past ... underfunded since 1996, and there is little prospect that the picture ... The report, Quiet No More: Philadelphia Confronts the ...
... AMSTERDAM, June 29 , ... Hiring and,Collaboration Decisions , Elsevier, ... and services, today announced the launch of SciVal,Spotlight, a ... of research performance to evaluate, establish,and execute more informed ...
... new type of body armour made from cement. The new ... make a material tough enough to withstand most types of bullets. ... is being carried out the School of Civil Engineering at the ... said: "By using cement instead of alumina we are confident we ...
Cached Medicine News:Health News:Air Methods Petitions NTSB for Reconsideration of Probable Cause Determination 2Health News:Black gay men may be at increased HIV risk 2Health News:Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers' Pensions and Health Care 2Health News:Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers' Pensions and Health Care 3Health News:Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers' Pensions and Health Care 4Health News:Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers' Pensions and Health Care 5Health News:Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers' Pensions and Health Care 6Health News:Elsevier Launches SciVal Spotlight: New Tool Provides Multidisciplinary View of Research Performance 2Health News:Elsevier Launches SciVal Spotlight: New Tool Provides Multidisciplinary View of Research Performance 3Health News:Elsevier Launches SciVal Spotlight: New Tool Provides Multidisciplinary View of Research Performance 4
(Date:3/31/2015)... Immune Pharmaceuticals Inc. ("Immune", the "Company") (NASDAQ: ... expand its planned bullous pemphigoid (BP) clinical development for ... Pemphigoid is an orphan auto-immune blistering disease of the ... Europe . As previously ... Phase II clinical trial in Israel ...
(Date:3/31/2015)... 2015 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... 150mg, 225mg and 300mg oral tablets, indicated for use ... market for Propafenone Hydrochloride 150mg, 225mg and 300mg tablets ... Arthur S. Przybyl , President and Chief ... launch of our fourth product from the portfolio of ...
(Date:3/31/2015)... 2015   Unique Pharmaceuticals , a 503B outsourcing ... the company has initiated sterile compounding operations meeting the ... a company is to meet and exceed industry standards," ... the new regulations is validation of our quality management ... of our industry, investing in its continued success and ...
Breaking Medicine Technology:Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 3Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 4ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 2Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 3
... Delivery System Has Potential to, Help Solve Radiation Therapy Access and ... ... Symposium, WASHINGTON, Sept. 8 Early clinical experience with the,FDA ... non-isotopic treatment is a viable,option for adjuvant therapy for early-stage breast ...
... Compared to FISH ... - Company to Include Reporting for HER2 Gene Expression in All Oncotype DX ... Reports by End ... GHDX ) today announced results from two studies demonstrating,that quantitative reporting for ...
Cached Medicine Technology:Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium 2Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium 3Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium 4Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 2Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 3Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 4Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 5
Inquire...
... Eliminate aerosol contamination, ... reactions in PCR. Hydrophobic, ... Only air can pass ... tips, in contrast to ...
300 L, Racked, Filtered, Pre-sterilized, 96 tips/rack Recommended for 250 and 300 L pipettes....
... Resistant Tips offer a safe alternative to ... designed for applications such as PCR(a), pipetting ... ART Tips are excellent for tissue culture, ... ART Tips prevent aerosol contaminants and liquids ...
Medicine Products: